Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-१.४१%
१,०७६.१३
-१५.३८
-१.४१%
—१,०९१.५११,०९०.४०१,०९०.४०१,०७३.६९——
SIXC
Communications
SIXC
Communications
SIXC
-०.५५%
६०६.७४
-३.३७
-०.५५%
—६१०.११६१०.११६१०.२९६०६.१७——
SIXE
Energy
SIXE
Energy
SIXE
+०.८८%
१,२४८.८२
+१०.८४
+०.८८%
—१,२३७.९८१,२३७.८३१,२५२.४११,२२५.०३——
SIXI
Industrials
SIXI
Industrials
SIXI
-१.१७%
१,७२४.३६
-२०.३५
-१.१७%
—१,७४४.७११,७४०.९५१,७४७.२९१,७२१.५७——
SIXM
Financials
SIXM
Financials
SIXM
-०.७२%
६३५.५९
-४.५९
-०.७२%
—६४०.१८६३९.९२६४३.१९६३४.७३——
SIXR
Staples
SIXR
Staples
SIXR
-०.७६%
८४३.१५
-६.४३
-०.७६%
—८४९.५८८४५.२७८५१.६८८३९.४७——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-०.५५%
२१६.२९
-१.१९
-०.५५%
—२१७.४८२१७.४८२१८.१६२१५.५१——
SIXT
Technology
SIXT
Technology
SIXT
+०.०८%
३,२६३.४१
+२.७२
+०.०८%
—३,२६०.६९३,२७३.३६३,२८७.८१३,२४०.७८——
SIXU
Utilities
SIXU
Utilities
SIXU
-०.३४%
९३९.२४
-३.२१
-०.३४%
—९४२.४५९३९.३९९४८.८०९३३.९८——
SIXV
Health care
SIXV
Health care
SIXV
-०.२९%
१,४६२.५६
-४.२४
-०.२९%
—१,४६६.८०१,४६४.७०१,४६७.१९१,४५८.३६——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-०.७१%
२,३८०.४०
-१७.१०
-०.७१%
—२,३९७.५०२,३९५.०३२,४१२.०१२,३७०.६४——
CSPCY:OTCMKTS
CSPC Pharmaceuticals Group ADR
US$ ४.३५
+१.१६%
(+०.०५०) 1D
मे ४, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CSPCY...
Open
US$ ४.३५
High
US$ ४.३५
Low
US$ ४.३५
Mkt. cap
९७.७९ अरब
Volume
४२१.००
52-wk high
US$ ५.८३
52-wk low
US$ २.७३
Beta
०.४१
Shares outstanding
२.८८ अरब
No. of employees
२० हजार
News stories
From sources across the web
Stock Titan
Stock Titan
·
१० मिनेट पहिले
New Absci hire gets option to buy 276,200 shares at $4.92
TradingKey
TradingKey
·
१९ मिनेट पहिले
Vanguard ETF Could Beat the S&P 500 Again in 2026 —— Why Investors Are Paying Attention
ChartMill
ChartMill
·
१ घण्टा पहिले
Backblaze (NASDAQ:BLZE) Soars on Q1 Beat, Raised Guidance
PR Newswire
PR Newswire
·
२ घण्टा पहिले
Cambium Networks Pursues Appeal of Nasdaq Delisting
Profile
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province. CSPC produces both active pharmaceutical ingredient and formulations. API products include penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products. CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP. CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises. One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion. CSPC Pharma is recognized as one of China's “500 Most Valuable Chinese Brands” and “Top 500 Chinese Enterprises.” Wikipedia
About CSPC Pharmaceuticals Group ADR
CEOZhang Cuilong
Employees१९.७ हजार
Founded१९९२
Headquarters-
Sector-
Websitecspc.com.hk
Previous reportsAll values in HKD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
७.०१ अरब
६.२६ अरब
६.६२ अरब
६.११ अरब
Cost of goods sold
२.३१ अरब
२.२५ अरब
२.२८ अरब
२.११ अरब
Cost of revenue
२.३१ अरब
२.२५ अरब
२.२८ अरब
२.११ अरब
Research and development expenses
१.३० अरब
१.३८ अरब
१.५० अरब
१.६२ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.८९ अरब
१.५६ अरब
१.९७ अरब
१.८७ अरब
Operating expense
३.१९ अरब
२.९४ अरब
३.४७ अरब
३.४९ अरब
Total operating expenses
५.५० अरब
५.२० अरब
५.७५ अरब
५.६० अरब
Operating income
१.५१ अरब
१.०६ अरब
८६.९६ करोड
५१.४७ करोड
Other non operating income
२७.८५ करोड
३५.९९ लाख
६४.५५ करोड
-४७.०४ करोड
EBT including unusual items
१.८० अरब
१.३२ अरब
१.१८ अरब
५०.५६ करोड
EBT excluding unusual items
१.८० अरब
१.१४ अरब
१.३७ अरब
१८.६६ करोड
Income tax expense
३०.१३ करोड
२४.२४ करोड
२२.२५ करोड
१६.५६ करोड
Effective tax rate
१६.७७%
१८.३४%
१८.७८%
३२.७६%
Other operating expenses
-
-
-
-
Net income
१.४८ अरब
१.०७ अरब
९६.३५ करोड
३७.०७ करोड
Net profit margin
२१.०७%
१७.०९%
१४.५६%
६.०६%
Earnings per share
-
-
-
-
Interest and investment income
-
९.५० करोड
-
१९.५९ करोड
Interest expense
-६७.३९ लाख
-१.४९ करोड
-१०.५२ करोड
-६७.५७ लाख
Net interest expenses
-६७.३९ लाख
८.०१ करोड
-१०.५२ करोड
१८.९१ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
१.७९ अरब
१.३६ अरब
१.१४ अरब
८०.२१ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer